Cargando…
Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS
BACKGROUND: In TAGS, an international, double-blind, phase 3 trial, trifluridine/tipiracil significantly improved overall survival and progression-free survival compared with placebo in heavily pretreated metastatic gastric cancer patients. This paper reports pre-specified quality of life (QoL) outc...
Autores principales: | Tabernero, Josep, Alsina, Maria, Shitara, Kohei, Doi, Toshihiko, Dvorkin, Mikhail, Mansoor, Wasat, Arkenau, Hendrik-Tobias, Prokharau, Aliaksandr, Ghidini, Michele, Faustino, Catia, Gorbunova, Vera, Zhavrid, Edvard, Nishikawa, Kazuhiro, Ando, Takayuki, Yalçın, Şuayib, Van Cutsem, Eric, Sabater, Javier, Skanji, Donia, Leger, Catherine, Amellal, Nadia, Ilson, David H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305098/ https://www.ncbi.nlm.nih.gov/pubmed/32128634 http://dx.doi.org/10.1007/s10120-020-01053-9 |
Ejemplares similares
-
Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy: Subgroup Analyses of a Randomized Clinical Trial
por: Ilson, David H., et al.
Publicado: (2019) -
Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study
por: Mansoor, Wasat, et al.
Publicado: (2021) -
Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study
por: Tabernero, J., et al.
Publicado: (2021) -
QTWiST analysis of the RECOURSE trial of trifluridine/tipiracil in metastatic colorectal cancer
por: Tabernero, Josep, et al.
Publicado: (2017) -
Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancer
por: Van Cutsem, E., et al.
Publicado: (2022)